SequelSEC

BioScience Health Innovations, Inc. BHIC

Services-Computer Processing & Data Preparation · CIK 0001784440 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$5.69M
Fiscal year ended 2025-12-31
Operating income
$719.05K
Fiscal year ended 2025-12-31
Free cash flow
Unavailable
Fiscal year ended 2025-12-31

BioScience Health Innovations, Inc. (BHIC) reported revenue of $5.69M and net income of $642.09K for the fiscal year ended 2025-12-31. This page shows 7 annual periods of income statement, balance sheet and cash flow figures normalized from BioScience Health Innovations, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Computer Processing & Data Preparation.

Income

BioScience Health Innovations, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312022-08-312021-08-312020-08-31
Revenue$5.69M$1.84M$597.60K$69.34K$0$0$0
Cost of revenue$2.45M$536.08K$113.19K$9.70KUnavailableUnavailableUnavailable
Gross profit$3.24M$1.31M$484.41K$59.64KUnavailableUnavailableUnavailable
Operating income$719.05K$87.00K-$251.50K-$170.45K-$91.92K-$25.61K-$7.68K
Net income$642.09K$87.00K-$251.50K-$170.45K-$83.21K-$25.61K-$7.68K
Research & development$37.54K$25.91K$0UnavailableUnavailableUnavailableUnavailable
Weighted-average diluted sharesshares 11.40Mshares 10.90Mshares 33.76MUnavailableUnavailableUnavailableUnavailable
Pretax incomeUnavailableUnavailableUnavailableUnavailable-$83.21K-$25.61KUnavailable
Income tax expense$76.96K$0$0$0$0$0$0
Diluted EPS$0.06$0.01$-0.01UnavailableUnavailableUnavailableUnavailable
Selling, general & administrative$2.21M$1.15M$706.26K$151.32K$91.92K$25.61K$7.68K
General & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable$7.68K
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

BioScience Health Innovations, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312022-08-312021-08-312020-08-31
Cash & equivalents$661.92K$662.52K$19.24K$11.57KUnavailable$2.04K$20.63K
Total assets$1.71M$873.79K$93.39K$31.61K$16.25K$6.31K$20.63K
Current assets$1.56M$847.75K$93.39K$31.61K$16.25K$6.31K$20.63K
Total liabilities$229.85K$38.55K$100.15K$48.79K$1.86K$19.11K$7.81K
Current liabilitiesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Total equity incl. NCI$1.48M$835.24K-$6.76K-$17.18K$14.39K-$12.79K$12.82K
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Inventory$336.35K$58.32K$37.70K$12.28KUnavailableUnavailableUnavailable
Accounts receivable$399.26K$100.28K$36.45K$7.76KUnavailableUnavailableUnavailable
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts payable$6.27K$8.23K$7.68K$3.44K$1.86K$0$760

Cash flow

BioScience Health Innovations, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312022-08-312021-08-312020-08-31
Operating cash flow$172.18K$23.19K-$307.84K-$182.78K-$85.78K-$29.44K-$7.68K
Capital expendituresUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Investing cash flow-$56.85K-$26.04K$0$0UnavailableUnavailable$0
Financing cash flow-$115.92K$646.13K$315.51K$194.25K$100.00K$10.84K$28.31K
Net change in cashUnavailableUnavailableUnavailableUnavailableUnavailable-$18.59K$20.63K
Stock-based compensationUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortizationUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Derived

BioScience Health Innovations, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312022-08-312021-08-312020-08-31
Free cash flowUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross margin57.0%70.9%81.1%86.0%UnavailableUnavailableUnavailable
Operating margin12.6%4.7%-42.1%-245.8%UnavailableUnavailableUnavailable
FCF marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
SBC / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Current ratioUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Revenue YoY growth208.3%208.7%761.8%UnavailableUnavailableUnavailableUnavailable
Net marginUnavailable4.7%-42.1%-245.8%UnavailableUnavailableUnavailable
R&D / revenueUnavailable1.4%0.0%UnavailableUnavailableUnavailableUnavailable
CapEx / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open BHIC in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-07View SEC filing
10-Q · Filed 2026-05-11View SEC filing
10-K · Filed 2026-03-30View SEC filing
10-Q · Filed 2025-10-27View SEC filing
10-Q · Filed 2025-08-07View SEC filing
10-Q · Filed 2025-05-08View SEC filing

Companies in the same industry

ADP ALIS APLD AUUD AVAI BIRD CARG CARS CLVT CRCW DTCX DTST

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.